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aThe recent outbreak of foot-and-mouth disease virus
(FMDV) on the European continent has had enormous
economic impact, highlighting the importance of future
measures to control this highly infectious agent. It has
been estimated that the recent FMDV outbreak in Great
Britain will result in a multi-billion-dollar loss in the cur-
rent year alone. In their article in this issue of Virology,
Baranowski and colleagues examine the relationship
between major antigenic epitopes and integrin receptor
binding sites on FMDV particles (Baranowski et al.,
2001). Earlier structural analyses of this virus (Archarya
et al., 1989; Verdaguer et al., 1996) in combination with
the new studies have increased our understanding of
picornavirus evolution and open up new avenues for
developing improved recombinant virus vaccines and
gene delivery vectors.
Several DNA- and RNA-containing viruses have been
shown to use av integrins (avb1, avb3, avb5, avb6) for
cell entry (Summerford et al., 1999; Guerrero et al., 2000;
oudais et al., 2000; Gavrilovskaya et al., 1998; Wickham
t al., 1993) (Table 1). In some instances, the Arg-Gly-Asp
RGD) sequence serves as the primary integrin binding
ite on the surface of virus particles. RGD sequences are
lso present in several extracellular matrix proteins in-
luding vitronectin and fibronectin; however, the resi-
ues immediately adjacent to the RGD motifs in viruses
nd host cell proteins are generally nonconserved. Inte-
rin binding sequences on other viruses such as hanta-
irus, canine adenovirus type 2 (CAV-2), rotavirus, and
denovirus-associated virus type 2 (AAV-2) have not yet
een identified. In the case of AAV-2, it is still unclear
hether this virus is capable of direct binding to av
integrins (Qiu et al., 1999). For a number of different
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ressed at Department of Immunology, IMM19, The Scripps Researchnstitute, 10550 North Torrey Pines Road, La Jolla, CA 92037. Fax: (858)
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189viruses, it appears that integrin binding domains may not
contain RGD motifs based on the failure of synthetic RGD
peptides to compete for virus infection. One possibility is
that polybasic sequences, such as those present in the
HIV Tat protein, can also mediate av integrin interactions
Vogel et al., 1993).
Interestingly, the RGD domains on the surface of Ad
nd FMDV particles have a very similar spatial orienta-
ion (Fig. 1) even though these viruses are evolutionarily
istinct (i.e., Ad but not FMDV has a fiber protein located
t each fivefold axis). The RGD domains of both viruses
re located at the apex of long flexible loops and have a
entameric arrangement with each RGD being spaced
pproximately 60 Å apart. This particular spacing allows
s many as five integrin molecules to bind per penton
ase on adenovirus particles. Moreover, the precise spa-
ial arrangement of the RGD motifs promotes integrin
lustering at the cell surface, an event that initiates cell
ignaling and virus internalization (Nemerow and Stew-
rt, 1999).
In contrast to pentavalent integrin binding to Ad parti-
les, only two to three antibody molecules directed
gainst the RGD motif can bind to each penton base
rotein due to steric hindrance from the central fiber
rotein and the close apposition of the RGD protrusions
Stewart et al., 1997). This results in at least one RGD on
ach penton being available for integrin association.
hus, the exposed integrin binding sites on Ad particles
re partially shielded from potentially neutralizing anti-
ody due to the structural features of the virus capsid.
The length of the RGD domain also regulates antibody
nd av integrin interactions. The penton base proteins of
most adenovirus serotypes have a conserved RGD motif
but have varying length flanking residues that comprise
a nonconserved central domain (Mathias et al., 1994).
For example, the penton base of adenovirus type 12 has
a relatively short RGD domain consisting of approxi-
mately 17 amino acids whereas Ad5 has a significantly
0042-6822/01 $35.00
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190 MINIREVIEWlonger domain with 80 residues. The shorter RGD loop
on Ad12 particles allowed structural analysis of bound
integrin molecules by cryoelectron microscopy, due to
the decreased mobility of the receptors (Chiu et al.,
1999). Interestingly, Ad12 infection can also be readily
inhibited with function-blocking anti-integrin antibodies
whereas Ad5 infection (Bai et al., 1994) requires higher
antibody concentrations. These findings suggest that the
longer and more flexible RGD domain of Ad5 promotes
higher affinity integrin association than the shorter RGD
loop of Ad12.
Specific residues immediately adjacent to the integrin
binding motif are also likely to influence receptor inter-
action (Assa-Munt et al., 2001). The penton bases of two
ubgroup D adenoviruses, Ad19p and Ad37, have similar
ength integrin binding domains; however, the residues
lanking the RGD motifs are different (Table 1). Ad37
articles also exhibit significantly higher avb5 integrin
inding than Ad19p (Mathias et al., 1998). Similar struc-
tural features may also regulate integrin binding to
FMDV. For example, a leucine residue immediately ad-
jacent to the aspartic acid in the RGD motif has been
previously reported to influence FMDV interaction with
integrins avb3 and a5b1 (Jackson et al., 2000).
The RGD loop in the VP1 protein of FMDV not only
serves as the receptor binding site on the virus but also
is part of a major antigenic site and therefore a target for
neutralizing antibodies in vivo. The conservation of the
RGD motif among different wild-type FMDV strains de-
spite the presence of neutralizing antibody to this do-
main suggests a crucial requirement for integrin interac-
tions in vivo. A key observation that shed further light on
the relationship of neutralizing epitopes and receptor
binding sites was that serial passage of field strains of
FMDV in vitro resulted in the generation of mutant vi-
ruses that lack the RGD motif (Jackson et al., 1996).
These mutant viruses instead use cell-surface heparan
sulfate proteoglycans (HSP) or perhaps other unidenti-
fied molecules as alternative receptors. The acquisition
of HSP binding is associated with an increase in posi-
TABLE 1
Examples of Viruses Reported to Use av Integrins
Virus Integrin Integrin-binding sequence
FMDV avb3, avb6 S A RGD L A
Ad2, Ad5 avb1, avb3, avb5 A I RGD T F
Ad37 avb3, avb5 V P RGD N Y
Ad19p avb5 E I RGD S A
CAV-2 avb5 Unknown
antavirus avb3 Unknown
IV Tat avb5 R K K R R Q R R R
otavirus avb3 Unknown
AV-2 avb5 Unknowntively charged amino acid residues at several different
sites on the virion particle.
(
sIn their current studies on FMDV, Baranowski and
colleagues examine the contribution of the residues
flanking the RGD domain to the major antigenic site. To
do this, these investigators replaced eight amino acids
including the RGD motif in VP1 with an antibody epitope
tag (Flag, DYKDDDDK). Recombinant viruses containing
the new epitope were able to replicate in vitro to wild-
type levels after multiple passages in tissue culture,
presumably because they acquired the ability to use
alternative receptors such as HSP. Importantly, the mu-
tated virions lack the major antigenic site and thus have
decreased susceptibility to antibody neutralization.
These findings indicate that FMDV particles can accom-
modate more severe mutations in the major antigenic
site without compromising the viability of the virus in
vitro.
Previous vaccine studies using inactivated FMDV par-
ticles showed that these virions are protective; however,
they suffer from the fact that the vaccine itself can occa-
sionally cause disease. More recent trials using recom-
binant FMDV vectors lacking the RGD domain appear to
be safer (McKenna et al., 1996) and it is possible that
articles containing further deletions in the RGD domain
ill have additional safety. Nonetheless, an inability to
istinguish vaccine from wild-type viruses in livestock
as tempered the widespread use of recombinant FMDV.
t is conceivable that infection with FMDV particles dis-
laying foreign peptide sequences in the RGD domain
ay provide an additional way to monitor vaccine dis-
emination. Whether these new epitopes will be retained
FIG. 1. A comparison of the adenovirus and foot-and-mouth disease
virus vertex regions. Both viruses have five RGD-containing protrusions
spaced by 60 Å around the icosahedral fivefold symmetry axes. The
penton base (yellow) and a short portion of the fiber (green) are shown
from a cryo-EM reconstruction of Ad2. A cryo-EM reconstruction of Ad2
complexed with an RGD-binding monoclonal antibody indicated that
the RGD region is at the top of each penton base protrusion (Stewart et
l., 1997). The first X-ray crystallographic structure of FMDV showed the
GD loop to be disordered and this density is represented with dotsAcharya et al., 1989). The FMDV structure figure is used with permis-
ion from Acharya et al. (1989).
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191MINIREVIEWduring the natural evolution of FMDV quasispecies re-
mains to be determined however. Regardless of their
practical value, the structure/function analyses of ade-
novirus and FMDV have improved our understanding of
the relationship of receptor and antibody epitopes on
nonenveloped viruses.
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